Expression of the Calcium-Binding Protein CALB1 Is Induced and Controls Intracellular Ca


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Aug 2022
Historique:
received: 01 07 2022
revised: 12 08 2022
accepted: 16 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

In response to many stresses, such as oncogene activation or DNA damage, cells can enter cellular senescence, a state of proliferation arrest accompanied by a senescence-associated secretory phenotype (SASP). Cellular senescence plays a key role in many physiopathological contexts, including cancer, aging and aging-associated diseases, therefore, it is critical to understand how senescence is regulated. Calcium ions (Ca

Identifiants

pubmed: 36012633
pii: ijms23169376
doi: 10.3390/ijms23169376
pmc: PMC9409414
pii:
doi:

Substances chimiques

CALB1 protein, human 0
Calbindin 1 0
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : French National Cancer Institute
ID : 2018-144

Références

Cancer Res. 2013 Oct 15;73(20):6334-45
pubmed: 24008317
Aging Cell. 2022 Jul;21(7):e13632
pubmed: 35653631
Cell Death Dis. 2014 Feb 27;5:e1089
pubmed: 24577087
Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a004051
pubmed: 20943758
Int J Mol Sci. 2018 Nov 02;19(11):
pubmed: 30400174
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16009-14
pubmed: 24043806
Nat Commun. 2022 Feb 17;13(1):956
pubmed: 35177596
Aging (Albany NY). 2016 Dec 8;8(12):3400-3418
pubmed: 27941214
Nature. 2009 Sep 10;461(7261):230-5
pubmed: 19701182
Front Cell Dev Biol. 2021 Mar 29;9:645593
pubmed: 33855023
Aging Cell. 2018 Jun;17(3):e12736
pubmed: 29446526
Int J Mol Sci. 2018 Sep 18;19(9):
pubmed: 30231482
Aging Cell. 2018 Dec;17(6):e12831
pubmed: 30216632
Int J Mol Sci. 2018 Sep 30;19(10):
pubmed: 30274399
J Biol Chem. 2013 Nov 8;288(45):32149-32159
pubmed: 24062309
Cell. 2019 Oct 31;179(4):813-827
pubmed: 31675495
Trends Cell Biol. 2018 Jun;28(6):436-453
pubmed: 29477613
Cancer Res. 2013 Aug 15;73(16):5253-65
pubmed: 23774215
FEBS Lett. 2012 Oct 19;586(20):3582-9
pubmed: 22982862
Trends Cell Biol. 2018 Apr;28(4):258-273
pubmed: 29409699
J Biol Chem. 2014 Feb 28;289(9):6188-98
pubmed: 24415751
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11282-7
pubmed: 22733741
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3227-32
pubmed: 9501245
Cancer Res. 2006 Nov 15;66(22):10805-14
pubmed: 17108117
Eur J Immunol. 2002 Oct;32(10):2971-8
pubmed: 12355451
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8668-73
pubmed: 21555587
Genes Dev. 2009 Apr 1;23(7):798-803
pubmed: 19279323
Oncogene. 2016 Jun 23;35(25):3282-92
pubmed: 26477312
J Biol Chem. 2000 Aug 25;275(34):26328-32
pubmed: 10835428
Biochem Biophys Res Commun. 2015 Sep 25;465(3):414-420
pubmed: 26260319
Nature. 2010 May 20;465(7296):368-72
pubmed: 20485437
Cell Calcium. 2018 Mar;70:16-23
pubmed: 28410770
Nat Commun. 2014 May 06;5:3792
pubmed: 24797322
Nat Commun. 2021 Feb 1;12(1):720
pubmed: 33526781
Cell Rep. 2021 Jul 27;36(4):109441
pubmed: 34320349
Nat Commun. 2017 May 10;8:14995
pubmed: 28489069
Mol Med Rep. 2019 Jun;19(6):5097-5104
pubmed: 31059057
Biochim Biophys Acta. 2015 Sep;1853(9):1974-9
pubmed: 25764980
Cell Syst. 2016 Feb 24;2(2):112-121
pubmed: 26942229
Cell Death Dis. 2013 Oct 10;4:e855
pubmed: 24113189
Nat Cell Biol. 2013 Aug;15(8):978-90
pubmed: 23770676

Auteurs

Clotilde Raynard (C)

Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, 69373 Lyon, France.

Nolwenn Tessier (N)

CarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, 69500 Bron, France.

Anda Huna (A)

Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, 69373 Lyon, France.

Marine Warnier (M)

Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, 69373 Lyon, France.

Jean-Michel Flaman (JM)

Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, 69373 Lyon, France.

Fabien Van Coppenolle (F)

CarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, 69500 Bron, France.

Sylvie Ducreux (S)

CarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, 69500 Bron, France.

Nadine Martin (N)

Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, 69373 Lyon, France.

David Bernard (D)

Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, 69373 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH